Fibralign Corporation
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Surgical Evaluation for Upper Extremity Lymphedema (BioBridge) (NCT05695924) | Fibralign Corporation | 2023-11-01 |
| LymphBridge: Surgical Evaluation for Breast Cancer-Associated Lymphedema (BioBridge) (NCT04606030) | Fibralign Corporation | 2020-10-26 |
Track Fibralign Corporation automatically
Every clearance here is in the API, with alerts when new ones post.